Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

The overall goal of this procedure is to utilize the antigen caps incorporation strategy for the development of adenovirus serotype five vectored vaccine approaches using a recombinant divalent adenoviral vector as a proof of principle by using the antigen capsid incorporation strategy, multiple cloning steps are used to construct the modified plasmid, A D five R one K-W-S-H-V-R five hiss. Next, the divalent adenyl viral vector. R one K was HVR five.

Hiss is rescued, propagated, and purified. Then the viral titers and the antigenic display of incorporated antigens on the viral capsid are characterized. Finally, the potential of the Divalent Aden viral vector to circumvent neutralization by a D five positive sera is evaluated by using the antigen capsid incorporation strategy.

Multiple cloning steps are used to construct the modified plasmid, A D five R one K-W-A-S-H-V-R five hiss. Today we will be demonstrating the antigen capsid incorporation strategy. This strategy is beneficial as compared to other strategies such as the transgene expression method because it not only displays the antigen of interest on the adenovirus captive as a protein, but it allows a robust humoral response against that antigen.

Visual demonstration of this method is critical as steps regarding the generation of the cap modifying adenovirus is difficult to learn because many variables contribute to the development of the recommended viral vectors, such as the selection of the restriction enzymes, the lens of the energy of interest in others Demonstrating the procedures. Today will be my two postdocs, Dr.Lin Lin Gu, and Dr.Nitra Farrow. Also Alexandre Kren, the research associate in the laboratory To construct the shuttle plasmid, add six units each of a GE one and a CCC one to six micrograms of the HVR one KWA fragment.

Incubate the digestion reaction at 37 degrees Celsius for three hours. Resolve the digestive fragment in a 2%agros gel by electrophoresis and use a DNA gel extraction kit according to the manufacturer's protocol to purify the fragment. Next, ligate 12 nanograms of the purified fragment into the a G one and ACC one sites of the 100 nanograms of the previously constructed shuttle plasmid.

HVR five hiss six pH five s and a 10 microliter reaction volume at room temperature for two hours. Then add one microliter of the ligation reaction to 50 microliters of electro competent DH five alpha cells, an electro eight before adding 950 microliters of SOC medium. Incubate the transformed cells at 37 degrees Celsius and 200 RPM for one hour before spreading 100 to 200 microliters of the culture onto an LB CANY plate.

Incubate overnight at 37 degrees Celsius. Use six units each of Echo R one and PME one to digest six micrograms of the purified shuttle plasmid at 37 degrees Celsius for three hours. After purifying the fragment containing homologous recombination arms and the dual modified exon five gene use SUA one to linearize the backbone plasmid, PAD five, delta H five to carry out homologous recombination.

Use electroporation to co transform 100 nanograms each of the purified shuttle fragment and the backbone plasmid into 50 microliters of electro competent BJ 5 180 3 cells. As demonstrated earlier in this video the following day, pick approximately 10 colonies into three milliliters of liquid LB containing can mycin and grow overnight before screening according to the text protocol. Then transform 100 nanograms of purified plasmid into DH five alpha cells as previously demonstrated to rescue the add viral vector.

Begin by using PAC one to linearize 15 microliters of the vector in a 100 microliter volume. Incubate at 37 degrees Celsius for three hours after the digestion. To extract the linearized plasmid under a fume hood.

Add an equal volume of phenol chloroform, isoamyl alcohol to the reaction centrifuge at 10, 000 G for one minute and collect supernatant before repeating the extraction and spin to the extracted volume. Add 300 microliters of 100%ethanol and 10 microliters of acetate spin at 10, 000 G for 10 minutes. Then after discarding the supernatant add 700 microliter of 70%ethanol before spinning again.

Once the pellet has been resuspended and the DNA has been quantified, transfect three micrograms of the linearized plasmid along with commercial liposomal transfection reagent into a previously prepared T 25 flask of 80%confluent HEK 2 93 cells according to the manufacturer's instructions. After incubating for six hours, replace the transfection medium with complete medium before returning the flask to the incubator. When plaques develop a full cytopathic effect or CPE under a sterile hood, scrape the remaining cells off the flask and centrifuge the culture at 300 G and four degrees Celsius for 10 minutes.

Then use one milliliter of medium containing 2%FBS to resuspend the cell pellet. Next, break the cells by carrying out four rounds of freeze thawing, then centrifuge the lysate at four degrees Celsius for 10 minutes. Collect the S supernatant containing the rescued virus to propagate the viral vector on a large scale culture.

One third to all of the viral lysate from the T 25 flask into a T 75 flask containing HEK 2 93 cells. After allowing full CPE to develop and harvesting the supinate as previously demonstrated, propagate half of all the virus in one or more. T 1 75 flasks of HK 2 93 cells then propagate the virus isolated from the T 1 75 flasks in one dozen or more.

T 1 75 flasks of cells after preparing one point 33 grams per milliliter and 1.45 grams per milliliter. Cesium chloride solutions add four milliliters, 1.33 grams per milliliter, cesium chloride to an ultracentrifuge tube and add four milliliters, 1.45 grams per milliliter, cesium chloride against the bottom of the same tube. Add four milliliters viral lysate supinate to the top of the same tube, then centrifuge the tube at 110, 000 G and four degrees Celsius for three hours.

This will separate the mature lower virus band from the defective higher virus band under the hood. Use a 33 gauge needle attached to a three milliliter syringe to collect the lower band. Then use five hippies to bring the solution up to four milliliters.

Then after preparing two more cesium chloride gradients, load the diluted virus on top and centrifuge the gradients at 110, 000 G and four degrees Celsius overnight. Under the hood. Collect the viral band as just demonstrated.

Then use a 33 gauge needle and three milliliter syringe to inject the virus solution into a dialysis cassette. Placed a cassette in 700 milliliters of one x dialysis buffer prepared according to the text protocol, replacing the buffer four times every three hours. Then using a needle and syringe.

Collect the viral solution from the cassette to determine the viral physical titer. Use virus lysis buffer to dilute both the virus and dialysis buffer used as a background control at one to 10 and one to 20 and incubate all the tubes at 56 degrees Celsius for 10 minutes. Turn on a bio photometer and set the mode of absorbance to an optical density of 260 nanometers.

Use the dialysis buffer diluted to one to 10 to balance the background signal by clicking the blank button. Type 10 plus 90 on the bio photometer screen. Replace the tube with tube of virus diluted to one to 10 and read the signal of the virus diluted to one to 10.

To measure the one to 20 dilution, use the dialysis buffer diluted to one to 20 to balance the background typing five plus 95 on the screen before replacing the buffer tube with a one to 20 diluted virus tube and reading the signal. Multiply the two virus readout numbers by 1.1 times 10 to the 12 and calculate the average titer with units of VP per milliliter based on the two individual titers from the two dilu. Evaluate the virus in mice according to the text protocol to demonstrate whether the rescued virus displays the antigenic HIV antigen and hist tag on the surface of the viral capsid.

Major protein Heon five. Eliza was carried out with the human two F five monoclonal antibody and mouse anti hiss tag monoclonal antibody respectively as shown here, both the human two F five antibody and mouse anti hiss antibody bound to the divalent add five virus particle, whereas there was no binding to the negative control. A five vector Western blood analysis was used to confirm the E iza data as both human two F five antibody and mouse anti hiss antibody detected Specific bands around 117 kilodaltons only.

In the DIVALENT add five virus, which corresponds to the size of Heon five protein. To evaluate the potential of the constructed add five virus to circumvent neutralization by add five positives, a neutralization assay was carried out. The results show that relative luminescent units or rlu were 12 times higher when the control add five vector was treated without add five positive serum than when it was treated with serum suggesting that the virus was neutralized.

In contrast, there was little difference in the R use for the constructed divalent AD five virus between treated and untreated samples suggesting that the constructed virus escaped neutralization. After watching this video, you should have a greater understanding of the antigen capsid incorporation approach for add five vector vaccine development. Currently, we are using this strategy in combination with rare serotype vectors.

You can do this as well.